Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-05

Clinical Trial Update: Thyrotropin Over-suppression and Heart

View source ↗

Summary

The clinical trial NCT02645786 has completed. It examines thyrotropin over-suppression and its impact on thyroid cancer and related heart conditions, including …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Chuncheon Sacred Heart Hospital | Conditions: Malignant Neoplasm of Thyroid, Heart Diseases | Status: COMPLETED